Alexey Vertegel to Recombinant Fusion Proteins
This is a "connection" page, showing publications Alexey Vertegel has written about Recombinant Fusion Proteins.
Connection Strength
0.028
-
A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis. Clin Exp Immunol. 2014 Aug; 177(2):500-8.
Score: 0.028